Delphine Vallot
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.
Journal: European thyroid journal
Published: March 25, 2025
Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu-labeled somatostatin-receptor therapy.
Journal: EJNMMI physics
Published: April 28, 2023
RadioLigand Therapy with [177Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 13, 2023
Radiation dose reduction during venous access port implantation: the importance of upgrading equipment and radiation-protection training.
Journal: Irish journal of medical science
Published: March 29, 2023
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 23, 2023
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project.
Journal: EJNMMI physics
Published: April 30, 2020
Gated 18F-FDG PET/CT of the Lung Using a Respiratory Spirometric Gating Device: A Feasibility Study.
Gated 18F-FDG PET/CT of the Lung Using a Respiratory Spirometric Gating Device: A Feasibility Study.
Journal: Journal of nuclear medicine technology
Published: November 13, 2018
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
Journal: Nuclear medicine communications
Published: May 24, 2018
A clinical evaluation of the impact of the Bayesian penalized likelihood reconstruction algorithm on PET FDG metrics.
Journal: Nuclear medicine communications
Published: October 19, 2017
Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.
Journal: Nuclear medicine communications
Published: July 19, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026